Argatroban Injection Recall: What To Do

Par health recall news matters to anyone who receives hospital injections. On October 28, 2026, the U.S. Food and Drug Administration recorded a Class I recall of Argatroban Injection from Par Health USA, LLC. The action covers 18,991 units of a 250 mg/2.5 mL single-dose vial. The stated problem is particulate matter in the product solution. Argatroban is a prescription blood thinner given by injection. As a result, patients, caregivers, and care facilities may want to know what this action means.

What the Par Health Recall Covers

The par health recall involves one injectable drug product. It is Argatroban Injection, USP, 250 mg/2.5 mL (100 mg/mL). Each package holds one 2.5 mL single-dose vial. The product is labeled “Rx only.” That means it is dispensed under a prescription, typically in a hospital or clinic setting.

The agency record lists two label versions. One reads “Manufactured for: Endo USA, Malvern, PA 19355.” The other reads “Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977.” The record lists the product code as NDC 42023-182-0. However, the agency data we reviewed does not list specific lot numbers or expiration dates. You should check the official notice for those details.

The FDA recall number is D-0082-2027. The agency recorded the action on October 28, 2026. The total scope is 18,991 units. Distribution dates and specific states are not stated in the record we reviewed. In most cases, injectable drugs like this one ship to hospitals, pharmacies, and wholesalers. They are not usually sold directly to consumers.

Because of that, most patients will never hold this vial themselves. For example, a nurse may give argatroban through an IV line during a hospital stay. Doctors often use it to prevent or treat blood clots in certain patients who cannot take heparin. Your care team is best placed to know which product you received. Your hospital pharmacy can also check its records.

The Hazard and Reported Injuries

The par health recall stems from particulate matter found in the solution. The FDA record names several materials. These are cellulose, polystyrene, polyethylene terephthalate, stainless steel, or stopper material. Cellulose is a plant-based fiber. Polystyrene and polyethylene terephthalate are common plastics. Stopper material refers to pieces of the rubber closure that seals the vial.

Foreign particles are a serious concern in injectable drugs. An injection goes directly into the bloodstream. Typically, the body cannot filter out particles the way it might with a swallowed pill. Health authorities have long warned about particles in IV drugs. Possible problems include blocked small blood vessels, local irritation, and inflammation. Allergic-type reactions are another concern. The risk may be higher for patients who are already seriously ill.

The FDA classified this action as Class I. That is the most serious recall category. It applies when there is a reasonable probability that using a product could cause serious health problems or death. However, a Class I label describes potential risk. It does not, by itself, confirm that anyone was harmed.

The agency record does not state whether any injuries have been reported. We are not making a claim either way. If you have concerns about your own treatment, talk with your doctor. You can also report a suspected reaction to the FDA through its MedWatch program. Reports like these help regulators track safety problems over time.

What To Do If You Own This Product

Most readers do not keep argatroban at home. Still, the par health recall calls for practical steps from patients, caregivers, and facilities. First, do not use any vial you believe may be affected. Set it aside in a safe, separate place. Do not throw it away until you have read the official instructions.

Next, identify the product. Look for “Argatroban Injection” and “250 mg/2.5mL (100 mg/mL)” on the label. Check for NDC 42023-182-0. Also look for the Endo USA or Par Pharmaceutical name. For example, a pharmacist can compare lot numbers against the official notice. If you are unsure, ask the pharmacy or facility that supplied the vial.

The remedy for this par health recall is not described on this page. The agency text we received did not match this product, so we withheld it. Instead, follow the instructions in the official FDA notice. You can find it through the FDA Enforcement Report database here:

FDA Enforcement Report – Drug Recalls

Search for recall number D-0082-2027 to locate the entry. If you received argatroban during a recent hospital stay, contact your doctor. They can review your records and explain any risk. Seek urgent care for symptoms like chest pain, trouble breathing, or sudden swelling. Health care facilities should review their inventory and follow standard recall procedures.

Does a Par Health Recall Mean You Can Sue?

A recall is not a lawsuit. It is a safety action meant to remove a product from use. The par health recall does not mean a court has found anyone at fault. It also does not create a legal claim by itself. We have not verified any lawsuit filed over this par health recall.

In most cases, a product liability claim needs more than a recall. Typically, a person must show they were actually harmed. They must also show the product likely caused that harm. Medical records, treatment dates, and product details all matter. As a result, two people linked to the same recall may face very different situations.

Some people may still have questions about their legal rights. A licensed attorney in your state can review your facts. Many product liability lawyers offer free consultations. However, no one can promise an outcome. You may be eligible to pursue a claim only if the facts and the law support it.

Time limits also matter. Every state sets deadlines for filing claims, called statutes of limitations. These deadlines vary from state to state. If you believe you were harmed, consider speaking with a lawyer sooner rather than later. Keep your treatment records, bills, and any product information in a safe place.

How Recalls Connect to Mass Tort Cases

Recalls sometimes become evidence in later litigation. A recall notice can show when a company learned about a problem. It can also describe the defect in official terms. Lawyers may use that record to support claims about design, manufacturing, or warnings. However, a recall is only one piece of evidence.

The Philips CPAP recall is one well-known example. In June 2021, Philips recalled millions of sleep apnea and breathing devices. The concern was sound-dampening foam that could break down. Many lawsuits followed. Federal courts grouped them into multidistrict litigation in Pennsylvania.

Takata airbags offer another example. Defective inflators led to the largest auto safety recall in U.S. history. Injury claims were consolidated in federal court in Florida. In both examples, individual cases still depended on proof of injury and causation. The recall alone did not decide them.

Whether the par health recall leads to any litigation is unknown. Many recalls never become lawsuits at all. For now, the best steps are practical ones. Follow the official notice, talk with your doctor, and keep good records.

Frequently Asked Questions

What is the par health recall about?

It covers Argatroban Injection, USP, 250 mg/2.5 mL single-dose vials. The FDA recorded it on October 28, 2026, as a Class I recall. The reason is particulate matter found in the product solution.

How many units are affected, and how do I find lot details?

The agency record lists 18,991 units under recall number D-0082-2027. Lot numbers are not included in the data we reviewed. Check the official FDA notice linked on this page for complete details.

Can I file a lawsuit because of the par health recall?

A recall alone is not a legal claim. If you were harmed and the product likely caused it, you may be eligible to pursue a claim. A licensed attorney can review your situation, but no outcome is guaranteed.

Were You Injured by a Recalled Product?

A recall by itself is a safety action, not a legal claim. However, if a recalled product caused a real injury, you may be eligible to pursue compensation. A licensed attorney can review your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover.

Official Sources & Resources

Verify every recall against the issuing agency before acting:

• U.S. Food and Drug Administration: official recall database — the record of truth for this notice
• CPSC: cpsc.gov — household goods, toys, furniture, appliances
• FDA: fda.gov — food, drugs, and medical devices
• NHTSA: nhtsa.gov — vehicles, tires, and child car seats
• USDA FSIS: fsis.usda.gov — meat, poultry, and egg products

Content last reviewed November 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

• All Product Recalls
• All Active MDL Cases
• Mass Tort Explainers
• Mass Tort Tips
• Tort Reform by State — 50-State Comparison

Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. A product recall is a safety action by a manufacturer or regulator and does not by itself establish liability or create a legal claim. No attorney-client relationship is created by accessing or using this content. Every case is unique. If you believe you were harmed by a recalled product, consult a licensed attorney in your jurisdiction.